Deciphering molecular mechanisms stabilizing the reovirus-binding complex.
atomic force microscopy
biophysics
glycan
molecular dynamics
virus
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
23 05 2023
23 05 2023
Historique:
medline:
17
5
2023
pubmed:
15
5
2023
entrez:
15
5
2023
Statut:
ppublish
Résumé
Mammalian orthoreoviruses (reoviruses) serve as potential triggers of celiac disease and have oncolytic properties, making these viruses potential cancer therapeutics. Primary attachment of reovirus to host cells is mainly mediated by the trimeric viral protein, σ1, which engages cell-surface glycans, followed by high-affinity binding to junctional adhesion molecule-A (JAM-A). This multistep process is thought to be accompanied by major conformational changes in σ1, but direct evidence is lacking. By combining biophysical, molecular, and simulation approaches, we define how viral capsid protein mechanics influence virus-binding capacity and infectivity. Single-virus force spectroscopy experiments corroborated by in silico simulations show that GM2 increases the affinity of σ1 for JAM-A by providing a more stable contact interface. We demonstrate that conformational changes in σ1 that lead to an extended rigid conformation also significantly increase avidity for JAM-A. Although its associated lower flexibility impairs multivalent cell attachment, our findings suggest that diminished σ1 flexibility enhances infectivity, indicating that fine-tuning of σ1 conformational changes is required to successfully initiate infection. Understanding properties underlying the nanomechanics of viral attachment proteins offers perspectives in the development of antiviral drugs and improved oncolytic vectors.
Identifiants
pubmed: 37186838
doi: 10.1073/pnas.2220741120
pmc: PMC10214207
doi:
Substances chimiques
Capsid Proteins
0
Viral Proteins
0
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2220741120Subventions
Organisme : NIAID NIH HHS
ID : R01 AI155646
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI174526
Pays : United States
Références
PLoS Pathog. 2008 Dec;4(12):e1000235
pubmed: 19079583
Nat Nanotechnol. 2017 Feb;12(2):177-183
pubmed: 27798607
J Immunol Methods. 2006 Jul 31;314(1-2):30-7
pubmed: 16822520
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
Nat Commun. 2019 Oct 1;10(1):4460
pubmed: 31575869
J Chem Phys. 2020 Oct 7;153(13):134104
pubmed: 33032427
J Virol. 2018 Jun 29;92(14):
pubmed: 29695426
Science. 2007 May 25;316(5828):1148-53
pubmed: 17525329
Methods Mol Biol. 2011;736:197-210
pubmed: 21660729
Phys Rev Lett. 2006 Mar 17;96(10):108101
pubmed: 16605793
J Virol. 2020 Nov 9;94(23):
pubmed: 32938765
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
Sci Adv. 2018 Aug 17;4(8):eaat1273
pubmed: 30128355
Bioconjug Chem. 2011 Jun 15;22(6):1239-48
pubmed: 21542606
Curr Top Microbiol Immunol. 2006;309:1-38
pubmed: 16909895
Oncolytic Virother. 2018 Jun 14;7:53-63
pubmed: 29942799
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Nat Methods. 2005 Jul;2(7):515-20
pubmed: 15973422
Science. 2017 Apr 7;356(6333):44-50
pubmed: 28386004
J Virol. 1988 Jan;62(1):246-56
pubmed: 3275434
J Virol. 1997 Jul;71(7):4921-8
pubmed: 9188554
Oncolytic Virother. 2014 Jul 09;3:69-82
pubmed: 27512664
Mol Ther. 2011 Jul;19(7):1199-211
pubmed: 21654634
Expert Opin Biol Ther. 2009 Jul;9(7):817-30
pubmed: 19527106
J Virol. 2015 Jun;89(11):6136-40
pubmed: 25810543
Annu Rev Virol. 2020 Sep 29;7(1):143-165
pubmed: 32396772
Biophys J. 1997 Apr;72(4):1541-55
pubmed: 9083660
EMBO J. 2002 Jan 15;21(1-2):1-11
pubmed: 11782420
Science. 1994 Sep 9;265(5178):1599-600
pubmed: 8079175
Nat Protoc. 2017 Nov;12(11):2275-2292
pubmed: 28981124
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Cell. 2006 Feb 24;124(4):729-40
pubmed: 16497584
PLoS Pathog. 2012;8(12):e1003078
pubmed: 23236285
J Am Chem Soc. 2023 Jan 11;145(1):70-77
pubmed: 36455202
J Am Chem Soc. 2017 Dec 13;139(49):17841-17852
pubmed: 29058444
J Virol. 2012 Aug;86(16):8346-58
pubmed: 22674975
Curr Protoc Microbiol. 2009 Aug;Chapter 15:Unit15C.1
pubmed: 19653214
Cell. 2001 Feb 9;104(3):441-51
pubmed: 11239401
Sci Rep. 2016 May 24;6:26536
pubmed: 27216779
J Cell Biol. 1993 Sep;122(5):1023-41
pubmed: 8394844
J Chem Phys. 2004 Apr 1;120(13):5946-61
pubmed: 15267476
Clin Cancer Res. 2001 Jan;7(1):120-6
pubmed: 11205899
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17778-83
pubmed: 18997008
PLoS Pathog. 2011 Aug;7(8):e1002166
pubmed: 21829363
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273
pubmed: 23341755
Biophys J. 1997 Apr;72(4):1568-81
pubmed: 9083662
J Biol Chem. 1998 Aug 7;273(32):20189-95
pubmed: 9685366
Ultramicroscopy. 2007 Oct;107(10-11):922-7
pubmed: 17560033
J Virol. 2000 Jan;74(1):42-8
pubmed: 10590089
Science. 1983 Aug 19;221(4612):709-13
pubmed: 6879170